Ignite Creation Date:
2024-05-05 @ 11:21 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00005779
Status:
COMPLETED
Last Update Posted:
2021-11-01
First Post:
2000-06-03
Brief Title:
Safety of the Candidate Vaccine C4-V3 Alone or With Interleukin-12 IL-12 in HIV-Infected Patients Receiving Effective Anti-HIV Drug Therapy
Sponsor:
National Institute of Allergy and Infectious Diseases NIAID
Organization:
National Institute of Allergy and Infectious Diseases NIAID
Key Dates - Follows AllAPIJSON File Order
Start Date:
None
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2004-05
Completion Date Type:
ACTUAL
First Submit Date:
2000-06-03
First Submit QC Date:
August 30 2001
Study First Post Date:
2001-08-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-10-28
Last Update Post Date:
2021-11-01
Last Update Post Date Type:
ACTUAL